메뉴 건너뛰기




Volumn 105, Issue 1, 2014, Pages 9-17

In vitro and ex vivo evaluation of a multi-epitope heparinase vaccine for various malignancies

Author keywords

Dendritic cells; Epitopes; Heparanase; Immunotherapy; Tumor antigens

Indexed keywords

ANTINEOPLASTIC AGENT; GAMMA INTERFERON; HEPARANASE; HEPARANASE 16 VACCINE; HEPARANASE 277 VACCINE; HEPARANASE 310 VACCINE; HEPARANASE 315 VACCINE; HEPARANASE 363 VACCINE; HEPARANASE 405 VACCINE; HEPARANASE 525 VACCINE; HEPARANASE 8 VACCINE; PEPTIDE VACCINE; TUMOR VACCINE; UNCLASSIFIED DRUG;

EID: 84892873839     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12308     Document Type: Article
Times cited : (8)

References (45)
  • 1
    • 80355147292 scopus 로고    scopus 로고
    • Type I interferon is selectively required by dendritic cells for immune rejection of tumors
    • Diamond MS, Kinder M, Matsushita H et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J Exp Med 2011; 208: 1989-2003.
    • (2011) J Exp Med , vol.208 , pp. 1989-2003
    • Diamond, M.S.1    Kinder, M.2    Matsushita, H.3
  • 2
    • 80355136945 scopus 로고    scopus 로고
    • Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
    • Fuertes MB, Kacha AK, Kline J et al. Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells. J Exp Med 2011; 208: 2005-16.
    • (2011) J Exp Med , vol.208 , pp. 2005-2016
    • Fuertes, M.B.1    Kacha, A.K.2    Kline, J.3
  • 3
    • 17144417748 scopus 로고    scopus 로고
    • Dendritic cells as therapeutic vaccines against cancer
    • Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005; 5: 296-306.
    • (2005) Nat Rev Immunol , vol.5 , pp. 296-306
    • Banchereau, J.1    Palucka, A.K.2
  • 4
    • 82755189230 scopus 로고    scopus 로고
    • Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients
    • Alfaro C, Perez-Gracia JL, Suarez N et al. Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients. J Immunol 2011; 187: 6130-42.
    • (2011) J Immunol , vol.187 , pp. 6130-6142
    • Alfaro, C.1    Perez-Gracia, J.L.2    Suarez, N.3
  • 5
    • 80052439234 scopus 로고    scopus 로고
    • Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients
    • Lesterhuis WJ, de Vries IJ, Schreibelt G et al. Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients. Clin Cancer Res 2011; 17: 5725-35.
    • (2011) Clin Cancer Res , vol.17 , pp. 5725-5735
    • Lesterhuis, W.J.1    de Vries, I.J.2    Schreibelt, G.3
  • 6
    • 79960900889 scopus 로고    scopus 로고
    • Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study
    • Bauer C, Dauer M, Saraj S et al. Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study. Cancer Immunol Immunother 2011; 60: 1097-107.
    • (2011) Cancer Immunol Immunother , vol.60 , pp. 1097-1107
    • Bauer, C.1    Dauer, M.2    Saraj, S.3
  • 7
    • 34447287858 scopus 로고    scopus 로고
    • Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate
    • Vlodavsky I, Ilan N, Naggi A, Casu B. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr Pharm Des 2007; 13: 2057-73.
    • (2007) Curr Pharm Des , vol.13 , pp. 2057-2073
    • Vlodavsky, I.1    Ilan, N.2    Naggi, A.3    Casu, B.4
  • 8
    • 0034845578 scopus 로고    scopus 로고
    • Molecular properties and involvement of heparanase in cancer progression and normal development
    • Vlodavsky I, Goldshmidt O, Zcharia E et al. Molecular properties and involvement of heparanase in cancer progression and normal development. Biochimie 2001; 83: 831-9.
    • (2001) Biochimie , vol.83 , pp. 831-839
    • Vlodavsky, I.1    Goldshmidt, O.2    Zcharia, E.3
  • 9
    • 0035999158 scopus 로고    scopus 로고
    • Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development
    • Vlodavsky I, Goldshmidt O, Zcharia E et al. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Semin Cancer Biol 2002; 12: 121-9.
    • (2002) Semin Cancer Biol , vol.12 , pp. 121-129
    • Vlodavsky, I.1    Goldshmidt, O.2    Zcharia, E.3
  • 10
    • 0037162555 scopus 로고    scopus 로고
    • Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis
    • Goldshmidt O, Zcharia E, Abramovitch R et al. Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis. Proc Natl Acad Sci U S A 2002; 99: 10031-6.
    • (2002) Proc Natl Acad Sci U S A , vol.99 , pp. 10031-10036
    • Goldshmidt, O.1    Zcharia, E.2    Abramovitch, R.3
  • 11
    • 77956624954 scopus 로고    scopus 로고
    • Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis
    • Barash U, Cohen-Kaplan V, Dowek I et al. Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis. FEBS J 2010; 277: 3890-903.
    • (2010) FEBS J , vol.277 , pp. 3890-3903
    • Barash, U.1    Cohen-Kaplan, V.2    Dowek, I.3
  • 12
    • 0025013701 scopus 로고
    • Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis
    • Vlodavsky I, Korner G, Ishai-Michaeli R, Bashkin P, Bar-Shavit R, Fuks Z. Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev 1990; 9: 203-26.
    • (1990) Cancer Metastasis Rev , vol.9 , pp. 203-226
    • Vlodavsky, I.1    Korner, G.2    Ishai-Michaeli, R.3    Bashkin, P.4    Bar-Shavit, R.5    Fuks, Z.6
  • 13
    • 0032417923 scopus 로고    scopus 로고
    • Inhibition of tumor invasion and metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green alga, Spirulina platensis
    • Mishima T, Murata J, Toyoshima M et al. Inhibition of tumor invasion and metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green alga, Spirulina platensis. Clin Exp Metastasis 1998; 16: 541-50.
    • (1998) Clin Exp Metastasis , vol.16 , pp. 541-550
    • Mishima, T.1    Murata, J.2    Toyoshima, M.3
  • 14
    • 34548474880 scopus 로고    scopus 로고
    • Dendritic cells reconstituted with a human heparanase gene induce potent cytotoxic T-cell responses against gastric tumor cells in vitro
    • Cai YG, Fang DC, Chen L et al. Dendritic cells reconstituted with a human heparanase gene induce potent cytotoxic T-cell responses against gastric tumor cells in vitro. Tumour Biol 2007; 28: 238-46.
    • (2007) Tumour Biol , vol.28 , pp. 238-246
    • Cai, Y.G.1    Fang, D.C.2    Chen, L.3
  • 15
    • 50949120270 scopus 로고    scopus 로고
    • HLA-A2-restricted cytotoxic T lymphocyte epitopes from human heparanase as novel targets for broad-spectrum tumor immunotherapy
    • Chen T, Tang XD, Wan Y et al. HLA-A2-restricted cytotoxic T lymphocyte epitopes from human heparanase as novel targets for broad-spectrum tumor immunotherapy. Neoplasia 2008; 10: 977-86.
    • (2008) Neoplasia , vol.10 , pp. 977-986
    • Chen, T.1    Tang, X.D.2    Wan, Y.3
  • 16
    • 77953058454 scopus 로고    scopus 로고
    • Cytotoxic T lymphocyte epitopes from human heparanase can elicit a potent anti-tumor immune response in mice
    • Tang XD, Liang GP, Li C et al. Cytotoxic T lymphocyte epitopes from human heparanase can elicit a potent anti-tumor immune response in mice. Cancer Immunol Immunother 2010; 59: 1041-7.
    • (2010) Cancer Immunol Immunother , vol.59 , pp. 1041-1047
    • Tang, X.D.1    Liang, G.P.2    Li, C.3
  • 17
    • 40449100254 scopus 로고    scopus 로고
    • H-2Kb-restricted CTL epitopes from mouse heparanase elicit an antitumor immune response in vivo
    • Tang XD, Wan Y, Chen L et al. H-2Kb-restricted CTL epitopes from mouse heparanase elicit an antitumor immune response in vivo. Cancer Res 2008; 68: 1529-37.
    • (2008) Cancer Res , vol.68 , pp. 1529-1537
    • Tang, X.D.1    Wan, Y.2    Chen, L.3
  • 18
    • 64549092429 scopus 로고    scopus 로고
    • Induction of anti-tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice
    • Chen L, Tang XD, Yu ST et al. Induction of anti-tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice. J Pathol 2009; 217: 685-92.
    • (2009) J Pathol , vol.217 , pp. 685-692
    • Chen, L.1    Tang, X.D.2    Yu, S.T.3
  • 19
    • 80051496177 scopus 로고    scopus 로고
    • Multiple antigenic peptides of human heparanase elicit a much more potent immune response against tumors
    • Wang GZ, Tang XD, Lü MH et al. Multiple antigenic peptides of human heparanase elicit a much more potent immune response against tumors. Cancer Prev Res (Phila) 2011; 4: 1285-95.
    • (2011) Cancer Prev Res (Phila) , vol.4 , pp. 1285-1295
    • Wang, G.Z.1    Tang, X.D.2    Lü, M.H.3
  • 20
    • 0035500466 scopus 로고    scopus 로고
    • Combining computer algorithms with experimental approaches permits the rapid and accurate identification of T cell epitopes from defined antigens
    • Schirle M, Weinschenk T, Stevanovic S. Combining computer algorithms with experimental approaches permits the rapid and accurate identification of T cell epitopes from defined antigens. J Immunol Methods 2001; 257: 1-16.
    • (2001) J Immunol Methods , vol.257 , pp. 1-16
    • Schirle, M.1    Weinschenk, T.2    Stevanovic, S.3
  • 21
    • 33947588271 scopus 로고    scopus 로고
    • Computational prediction and identification of HLA-A2.1-specific Ebola virus CTL epitopes
    • Sundar K, Boesen A, Coico R. Computational prediction and identification of HLA-A2.1-specific Ebola virus CTL epitopes. Virology 2007; 360: 257-63.
    • (2007) Virology , vol.360 , pp. 257-263
    • Sundar, K.1    Boesen, A.2    Coico, R.3
  • 22
    • 0025232814 scopus 로고
    • Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids
    • Fields GB, Noble RL. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int J Pept Protein Res 1990; 35: 161-214.
    • (1990) Int J Pept Protein Res , vol.35 , pp. 161-214
    • Fields, G.B.1    Noble, R.L.2
  • 23
    • 0028285230 scopus 로고
    • Proliferating dendritic cell progenitors in human blood
    • Romani N, Gruner S, Brang D et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994; 180: 83-93.
    • (1994) J Exp Med , vol.180 , pp. 83-93
    • Romani, N.1    Gruner, S.2    Brang, D.3
  • 24
    • 0029858032 scopus 로고    scopus 로고
    • Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors
    • Garrigan K, Moroni-Rawson P, McMurray C et al. Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors. Blood 1996; 88: 3508-12.
    • (1996) Blood , vol.88 , pp. 3508-3512
    • Garrigan, K.1    Moroni-Rawson, P.2    McMurray, C.3
  • 25
    • 34247637147 scopus 로고    scopus 로고
    • Heparanase: a target for drug discovery in cancer and inflammation
    • McKenzie EA. Heparanase: a target for drug discovery in cancer and inflammation. Br J Pharmacol 2007; 151: 1-14.
    • (2007) Br J Pharmacol , vol.151 , pp. 1-14
    • McKenzie, E.A.1
  • 26
    • 84861133191 scopus 로고    scopus 로고
    • Vaccines for melanoma and renal cell carcinoma
    • Kaufman HL. Vaccines for melanoma and renal cell carcinoma. Semin Oncol 2012; 39: 263-75.
    • (2012) Semin Oncol , vol.39 , pp. 263-275
    • Kaufman, H.L.1
  • 27
    • 77951554477 scopus 로고    scopus 로고
    • Patented cancer vaccines: the promising leads
    • Aurisicchio L, Ciliberto G. Patented cancer vaccines: the promising leads. Expert Opin Ther Pat 2010; 20: 647-60.
    • (2010) Expert Opin Ther Pat , vol.20 , pp. 647-660
    • Aurisicchio, L.1    Ciliberto, G.2
  • 28
    • 74049106976 scopus 로고    scopus 로고
    • Current developments with peptide-based human tumor vaccines
    • Khazaie K, Bonertz A, Beckhove P. Current developments with peptide-based human tumor vaccines. Curr Opin Oncol 2009; 21: 524-30.
    • (2009) Curr Opin Oncol , vol.21 , pp. 524-530
    • Khazaie, K.1    Bonertz, A.2    Beckhove, P.3
  • 30
    • 41149160918 scopus 로고    scopus 로고
    • Antigen-specific immunotherapy of cervical and ovarian cancer
    • Hung CF, Wu TC, Monie A, Roden R. Antigen-specific immunotherapy of cervical and ovarian cancer. Immunol Rev 2008; 222: 43-69.
    • (2008) Immunol Rev , vol.222 , pp. 43-69
    • Hung, C.F.1    Wu, T.C.2    Monie, A.3    Roden, R.4
  • 33
    • 33646755569 scopus 로고    scopus 로고
    • Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity
    • Smyth MJ, Dunn GP, Schreiber RD. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol 2006; 90: 1-50.
    • (2006) Adv Immunol , vol.90 , pp. 1-50
    • Smyth, M.J.1    Dunn, G.P.2    Schreiber, R.D.3
  • 34
    • 4444243096 scopus 로고    scopus 로고
    • Tumor-specific shared antigenic peptides recognized by human T cells
    • Van Der Bruggen P, Zhang Y, Chaux P et al. Tumor-specific shared antigenic peptides recognized by human T cells. Immunol Rev 2002; 188: 51-64.
    • (2002) Immunol Rev , vol.188 , pp. 51-64
    • Van Der Bruggen, P.1    Zhang, Y.2    Chaux, P.3
  • 35
    • 70449360735 scopus 로고    scopus 로고
    • Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma
    • Bonertz A, Weitz J, Pietsch DH et al. Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma. J Clin Invest 2009; 119: 3311-21.
    • (2009) J Clin Invest , vol.119 , pp. 3311-3321
    • Bonertz, A.1    Weitz, J.2    Pietsch, D.H.3
  • 37
    • 4644324025 scopus 로고    scopus 로고
    • Cancer immunotherapy: moving beyond current vaccines
    • Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nat Med 2004; 10: 909-15.
    • (2004) Nat Med , vol.10 , pp. 909-915
    • Rosenberg, S.A.1    Yang, J.C.2    Restifo, N.P.3
  • 38
    • 78650348177 scopus 로고    scopus 로고
    • Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination
    • Noguchi M, Mine T, Komatsu N et al. Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination. Cancer Biol Ther 2011; 10: 1266-79.
    • (2011) Cancer Biol Ther , vol.10 , pp. 1266-1279
    • Noguchi, M.1    Mine, T.2    Komatsu, N.3
  • 39
    • 26244445001 scopus 로고    scopus 로고
    • Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing
    • Strehl B, Seifert U, Kruger E, Heink S, Kuckelkorn U, Kloetzel PM. Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing. Immunol Rev 2005; 207: 19-30.
    • (2005) Immunol Rev , vol.207 , pp. 19-30
    • Strehl, B.1    Seifert, U.2    Kruger, E.3    Heink, S.4    Kuckelkorn, U.5    Kloetzel, P.M.6
  • 40
    • 0035796461 scopus 로고    scopus 로고
    • Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products
    • Toes RE, Nussbaum AK, Degermann S et al. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J Exp Med 2001; 194: 1-12.
    • (2001) J Exp Med , vol.194 , pp. 1-12
    • Toes, R.E.1    Nussbaum, A.K.2    Degermann, S.3
  • 41
    • 0033662405 scopus 로고    scopus 로고
    • CD4 +  T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells
    • Qin Z, Blankenstein T. CD4 +  T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. Immunity 2000; 12: 677-86.
    • (2000) Immunity , vol.12 , pp. 677-686
    • Qin, Z.1    Blankenstein, T.2
  • 43
    • 0033804943 scopus 로고    scopus 로고
    • Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation
    • Vaday GG, Lider O. Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation. J Leukoc Biol 2000; 67: 149-59.
    • (2000) J Leukoc Biol , vol.67 , pp. 149-159
    • Vaday, G.G.1    Lider, O.2
  • 44
    • 33646883248 scopus 로고    scopus 로고
    • Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells
    • Benhamron S, Nechushtan H, Verbovetski I et al. Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells. J Immunol 2006; 176: 6417-24.
    • (2006) J Immunol , vol.176 , pp. 6417-6424
    • Benhamron, S.1    Nechushtan, H.2    Verbovetski, I.3
  • 45
    • 0033151591 scopus 로고    scopus 로고
    • The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes
    • Vonderheide RH, Hahn WC, Schultze JL, Nadler LM. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity 1999; 10: 673-9.
    • (1999) Immunity , vol.10 , pp. 673-679
    • Vonderheide, R.H.1    Hahn, W.C.2    Schultze, J.L.3    Nadler, L.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.